NOTICE AND PROXY STATEMENT

Company

Sonoma Pharmaceuticals, Inc.

Filed

July 28, 2015

Period of Report

September 10, 2015

Accession Number

0001019687-15-002869

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →